Dopamine Transporter Imaging in Neurological Practice
November 20, 2009 - Prague, Czech Republic
Sponsored by the Movement Disorder Society - European Section
Supported in part by an unrestricted educational grant from
Evzen Ruzicka, MD, DSc
This workshop introduced participants to the potential of dopamine transporter single photon emission computed tomography (SPECT) imaging in neurological practice. The workshop answered some common questions, such as when it is appropriate for dopamine transporter imaging to be ordered by general practitioners, neurologists or Movement Disorder specialists. While some questions can be answered by a number of published dopamine transporter imaging studies of high scientific standard, answers to other questions are highly dependent upon expert opinion. The goal of the workshop was to present a balanced view of the currently available information on dopamine transporter imaging studies. The scope of information presented and discussed was chosen to not only identify the potential usefulness of dopamine transporter imaging in neurological practice, but also to guard against indiscriminate and injudicious use of dopamine transporter imaging, or erroneous interpretation of findings.
Participants in this activity learend to:
- List the disease/symptoms for which dopamine transporter imaging may be an appropriate investigative tool;
- Explain how patients suitable for this procedure would be identified;
- Describe how dopamine transporter imaging is performed and discuss the science underlying the procedure;
- Discuss the interpretation of dopamine transporter images;
- Discuss the current uses, potential future uses, and limitations of dopamine transporter imaging in neurological clinical practice, and research applications.
This course was recommended for specialists or trainees in Movement Disorders, and general neurologists.